Journal: Scientific Reports
Article Title: Whole-genome sequence and resistance determinants of four Elizabethkingia anophelis clinical isolates collected in Hanoi, Vietnam
doi: 10.1038/s41598-024-57564-3
Figure Lengend Snippet: Antimicrobial susceptibility testing of EAV_NVB490, EAV_NNN508, EAV_VTKC53 and EAV_NVH72 using the VITEK2 Compact system (MIC, in mg/L; left) and DDT (inhibition zone diameter, in mm; right).
Article Snippet: Upon arrival at USTH, the Kirby-Bauer Disk Diffusion Susceptibility Test (DDT) was used with 43 antibiotics (Thermo Scientific, UK): ampicillin (10 μg), penicillin G (1UI), oxacillin (5 μg), temocillin (30 μg), ticarcillin (75 μg), amoxicillin/clavulanic acid (20/10 μg), ticarcillin/clavulanic acid (75/10 μg), piperacillin/tazobactam (100/10 μg), cefotaxime (30 μg), cefoxitin (30 μg), cefepime (30 μg), ceftazidime (30 μg), cefpodoxime (10 μg), cephalexin (30 μg), imipenem (10 μg), meropenem (10 μg), ertapenem (10 μg), aztreonam (30 μg), gentamicin (10 μg), tobramycin (10 μg), amikacin (30 μg), kanamycin (30 μg), netilmicin (10 μg), ciprofloxacin (5 μg), norfloxacin (10 μg), levofloxacin (5 μg), ofloxacin (5 μg), nalidixic acid (30 μg), trimethoprim/sulfamethoxazole (1.25/23.75 μg), colistin (10 μg), tetracycline (30 μg), minocycline (30 μg), erythromycin (15 μg), chloramphenicol (30 μg), rifampicin (5 μg), vancomycin (5 μg), teicoplanin (30 μg), fusidic acid (10 μg), fosfomycin (200 μg), linezolid (10 μg), pristinamycin (15 μg), clindamycin (2 μg) and lincomycin (15 μg) following the method described in the CLSI guidelines (CLSI M02, 13th edition, 2018).
Techniques: Inhibition